share_log

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Meeshanthini

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Meeshanthini

4/A:持股变动声明(修正)-高管 Dogan Meeshanthini
美股SEC公告 ·  10/08 22:46

Moomoo AI 已提取核心信息

On September 6, 2024, Meeshanthini Dogan, the Chief Executive Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed a purchase of company stock. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Dogan's direct holdings in the company increased to a total of 1,655,429 shares. The purchase, conducted on the open market, reflects the CEO's direct investment in the company's stock and is a matter of record for investors monitoring insider activity.
On September 6, 2024, Meeshanthini Dogan, the Chief Executive Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed a purchase of company stock. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Dogan's direct holdings in the company increased to a total of 1,655,429 shares. The purchase, conducted on the open market, reflects the CEO's direct investment in the company's stock and is a matter of record for investors monitoring insider activity.
2024年9月6日,Cardio Diagnostics Holdings, Inc. [CDIO]的首席执行官Meeshanthini Dogan完成了一笔公司股票交易。该交易涉及以0.29美元的价格购买68965股普通股。在此交易之后,Dogan在公司的直接持股增加到了总共1655429股。这笔购买是在公开市场上进行的,反映出首席执行官对公司股票的直接投资,并且是投资者监控内部人员活动的记录事项。
2024年9月6日,Cardio Diagnostics Holdings, Inc. [CDIO]的首席执行官Meeshanthini Dogan完成了一笔公司股票交易。该交易涉及以0.29美元的价格购买68965股普通股。在此交易之后,Dogan在公司的直接持股增加到了总共1655429股。这笔购买是在公开市场上进行的,反映出首席执行官对公司股票的直接投资,并且是投资者监控内部人员活动的记录事项。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息